Advanced Search

Urology Coding Alert

You Be the Coder:

Report Coaptite® Injections Regardless of Gender

Published on Wed Apr 11, 2012

Question: We have a male patient that our doctor would like to inject with Coaptite® because of stress incontinence following a radical prostatectomy. The literature states that it is for use in adult females, but the rep from Boston Scientific states he has a urologist doing them on males and getting paid. The patient has Medicare insurance coverage. Can we report this procedure to Medicare for a male patient, and if so, how?Wisconsin SubscriberAnswer: You can report this procedure for either male or female patients. You would use CPT® code 51715 (Endoscopic injection of implant material into the submucosal tissues of the urethra and/or bladder neck) regardless of the patient's gender. Don't miss: For the implant material you should also report HCPCS code L8606 (Injectable bulking agent, synthetic implant, urinary tract, 1 ml syringe, includes shipping and necessary supplies) times the number of syringes used to the local payer who is reimbursing for [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Urology Coding Alert

View All